1. Introduction {#sec1-pathogens-06-00045}
===============

Serological methods such as single radial haemolysis (SRH), haemagglutination inhibition (HI) and microneutralization (MN) are cost-effective and widely-used methodologies to monitor the circulation and prevalence of influenza viruses, and are also employed in vaccine immunogenicity studies \[[@B1-pathogens-06-00045]\]. However, these assays have numerous shortcomings, especially related to the variability of the reagents, their standardization between laboratories, and their ability to detect haemagglutinin (HA) stalk-directed antibodies. Enzyme-linked immunosorbent assays (ELISAs) are used to detect stalk-directed antibodies, but are unable to differentiate between binding and neutralizing antibodies.

Recently, the use of replication-deficient viruses in neutralization assays has been widely evaluated as a potential alternative to MN assays. For example, HA pseudotype particles (pp) harbouring the HA embedded in the viral envelope and having a lentiviral vector as backbone have been used effectively for this purpose \[[@B2-pathogens-06-00045],[@B3-pathogens-06-00045]\]. The pseudotype particle neutralization test (pp-NT) appears to be more sensitive than other functional assays in the detection of the antibody response directed against the HA stalk \[[@B4-pathogens-06-00045]\]. Consequently, pp could be used to effectively study heterosubtypic antibody responses directed against the HA stalk region. Importantly, pp-NTs have been shown to correlate strongly with other classical serological assays \[[@B5-pathogens-06-00045],[@B6-pathogens-06-00045],[@B7-pathogens-06-00045],[@B8-pathogens-06-00045]\]. Since pp are replication-defective, they offer a safe alternative to wild-type virus methods (that require Biosafety Level 3 containment), and the detection of antibody responses is not influenced by the variability of blood-based reagents as observed in other assays (i.e., red blood cells in HI). Unfortunately, the validation of pp-NT, which will permit its more extensive use in surveillance as well as in pre-clinical and clinical studies, has not yet been established. The validation of pp-NT will allow the certification of its use in product release and stability control (if, in the future, HA stalk-directed monoclonal antibodies will be licensed) and in evaluating antibody responses elicited by current and "next-generation universal" influenza vaccines.

The availability of appropriate reference materials is essential for the optimization and validation of an assay. Appropriate reference standards are especially useful when the specificity, sensitivity, precision, and accuracy of an assay are evaluated for the first time \[[@B9-pathogens-06-00045]\], but are also essential when other assay parameters (e.g., dilution range or calibration curves) are established \[[@B10-pathogens-06-00045]\]. Furthermore, reference standards have an essential role in monitoring assay stability and consistency over different analytical sessions (e.g., days) \[[@B11-pathogens-06-00045]\]. Reference materials are also useful when multisite validation of an assay is performed. For example, the use of reference standard sera has been shown to be extremely useful to increase consistency between laboratories using HI and SRH \[[@B12-pathogens-06-00045]\]. Chicken reference antisera against all the HA subtypes are commonly generated and used for influenza virus typing in the HI assay \[[@B13-pathogens-06-00045],[@B14-pathogens-06-00045]\], and thus should be investigated as possible controls and reference materials in pp-NTs, which was the purpose of this study.

2. Results and Discussion {#sec2-pathogens-06-00045}
=========================

We have evaluated the neutralization activity and cross-reactivity of chicken reference antisera against a panel of pp bearing HAs of a representative strain (where possible of avian origin), for each HA subtype. Unfortunately, H6 and H13 influenza pp were not used in this study since appropriate pp bearing the HA of these two subtypes were not available.

The neutralizing titres resulting after analysis with GraphPad Prism software were elaborated using Microsoft Excel and the statistical software R to generate a "heat map" ([Figure 1](#pathogens-06-00045-f001){ref-type="fig"}). Phylogenetic analysis was also used to highlight relationships between HA subtypes. Observing [Figure 1](#pathogens-06-00045-f001){ref-type="fig"}, some features of the cross-reactivity map become immediately discernible: in the top left, there are Group 1 HA pp against Group 1 reference antisera, in the bottom right there are Group 2 HA pp against Group 2 reference antisera, and in the bottom left and top right there are the results of pp tested with reference antisera from a different group. The cross-reactivity map diagonal represents pp that were tested against matching antisera, and as expected, the higher neutralization titres are usually found in this part of the table. It can also be noticed that two map-shifts are present, since the H6pp and H13pp are missing. A clear symmetry can be visualised using the diagonal as symmetry axis, and in general, high neutralization titres are found when pp are tested with antisera of the same group (top left and bottom right). Conversely, sometimes antisera neutralize pp that harbour HAs of a completely different subtype/group. Other important features are that pp were usually neutralized by antisera generated against closely related viruses: in fact, using the two phylogenetic trees as guides, it is possible to identify clusters of darker green in relation to phylogenetic clades; for example, the H2-H5, H12-H8-H9, H11-H16-H13, H4-H14, and H7-H15. The cross-reactivity heat map shows that influenza reference antisera are usually able to efficiently neutralize HA-matched pp, and minor variation in the neutralizing titres can be observed when the serum was generated against paired (same subtype but different strain) HAs. Additionally, cross-reactive responses can be detected not only when phylogenetic relationships are present between the HA of the pp tested and the HA used as antigens to generate the antisera, but also between HA and antisera that share less similarity ([Figure 1](#pathogens-06-00045-f001){ref-type="fig"}).

Looking at [Figure 1](#pathogens-06-00045-f001){ref-type="fig"}, distinctive cross-reactivities can be observed. H1pp was highly neutralized by the matched antisera, but not by antisera generated against closely related HAs (H2/H5); however, it was neutralized by other Group 1 antisera (H8N4 and H11N9) and additionally by three Group 2 antisera. The H2pp and H5pp were neutralized by each other's antisera, by the antisera generated against the most closely related HAs (H1 and H6), but also by H8N4, H9N2, and H11N9 antisera. Even though closely related, H8pp and H12pp did not exhibit neutralization by each other's antisera; however, they were neutralized by the antisera generated against the closely related H9N2. Furthermore, H8pp was also neutralized by the antisera generated against H1-H2-H5, and by some antisera of Group 2, especially the ones generated against H7 viruses. All the antisera, without distinction of HA subtype, neutralized H9pp: higher neutralization activities were detected for Group 1 antisera, for H14N5 and H7 antisera, especially anti-H7N7. H11pp and H16pp were neutralized by their matched antisera and by antisera generated against other closely related HA, and by H1N1 antisera. For H16pp, neutralization activity was also detected when H12N5, H8N4, and H7 antisera were used. For Group 2 pp, A/Udorn/207/1972 H3pp (a human isolate) was poorly neutralized by the matched avian antisera, but was neutralized by the anti-H7N2 sera, one of the H7N7 antisera, and by numerous Group 1 antisera. H4pp was neutralized by all Group 2 antisera and by the H9N2 antisera. H14pp was neutralized by the matching antisera and by the antisera generated against the closely related H4. H7pp and H15pp were neutralized by their matched antisera and by each other's antisera; Group 1 sera were also found to cross-react with H15pp and some (H6N2 and H13N9) also with H7pp. H10pp was only neutralized by its matching antisera and not by any others.

Many studies have previously observed that chicken antisera generated using whole virus present a lower specificity in HI and/or immunodot-blot assays in comparison to the ones generated through HA-expressing DNA vaccination or recombinant HA1 vaccination \[[@B15-pathogens-06-00045],[@B16-pathogens-06-00045]\]. However, since a certain level of cross-reactivity is also observed with DNA or recombinant protein vaccination, cross-reactive HA-directed antibodies are likely involved \[[@B16-pathogens-06-00045]\].

In this study, commonly used reference antisera (for haemagglutination inhibition assay, agar gel immunodiffusion test, and agar gel precipitation test) show high neutralizing responses and cross-reactivity between different strains/subtypes. This could be problematic not only for HI typing, but especially for pp-NT. In fact, in the dilution range analysed, the pp-NT could not discriminate between two distinct pp (e.g., H16 pp was neutralized at the same dilution tested by both H16N3 and H13N6 sera). Preparation of the standard material through dilution of the commonly used reference standard or the use of monoclonal antibody mixtures (with or without the presence of a serum matrix) showing high specificity could be more effective approaches to establish reference materials to be used to validate, standardise, and control pp-NTs. To better understand which factors are underlying the observed cross-reactivity, we have evaluated the percentage amino acid identity between the HAs present on the pp and the HAs used for antisera generation. A percentage-identity heat map was then produced ([Figure 2](#pathogens-06-00045-f002){ref-type="fig"}).

This map shows a similar overall pattern to the cross-reactivity map ([Figure 1](#pathogens-06-00045-f001){ref-type="fig"}). There is a symmetry following the diagonal, the darker green is concentrated in the top left and bottom right sectors of the map. However, compared to the previous map ([Figure 1](#pathogens-06-00045-f001){ref-type="fig"}), dark green cannot be observed in the two other sectors of the maps; thus, as expected, the similarity between strains belonging to different groups is low. Since it is difficult to highlight all the differences and similarities by eye, statistical analysis was performed to see whether any concordance or association between the maps was present. Kendall τ test shows that there is low association between percentage identity and neutralization titres (τ = 0.225, *p* = 2.38 × 10^−7^). This means that the percentage amino acid identity is a good approach to evaluate the cross-reactivity response, but other approaches should be used to understand and explain the cross-reactivity detected. Antigenic cartography has recently been used to evaluate the antigenic evolution/drift of different influenza viruses and to help vaccine strain selection \[[@B17-pathogens-06-00045],[@B18-pathogens-06-00045]\]. This methodology could be used to analyse the data presented here, and should permit a representation of the antigenic interplay between different pp. In the absence of appropriate controls and the presence of high cross-reactivity responses, it will be difficult to assess the specificity of the pp-NT assay. Other parameters should be evaluated to understand if factors unrelated with the sera antibody content could interfere with the pp-NT assay. For example, the presence of virus-attachment inhibitors in the sera and serum treatments (e.g., heat-inactivation, pre-treatment with receptor-destroying enzymes) and/or the presence and type of adjuvant used can be assessed to optimise pp-NT assay conditions and to reduce non-specific neutralization if present. Additionally, the evaluation of possible haemolysis or other contaminants (e.g., lipids) of the serum samples is a factor that needs to be taken into consideration when the assay is optimised and validated \[[@B9-pathogens-06-00045]\].

3. Materials and Methods {#sec3-pathogens-06-00045}
========================

3.1. Reference Sera {#sec3dot1-pathogens-06-00045}
-------------------

The avian reference hyperimmune sera used for these studies and associated HI titres were provided by Dr. Giovanni Cattoli when he was at the Istituto Zooprofilattico delle Venezie (IZSVe), World Organization for Animal Health (OIE), Legnaro, Padua, Italy, and are reported in [Table 1](#pathogens-06-00045-t001){ref-type="table"}.

Reference avian sera against H5 and H7 influenza strains were provided by the Animal and Plant Health Agency (APHA, previously Animal Health and Veterinary Laboratories Agency) and are reported in [Table 2](#pathogens-06-00045-t002){ref-type="table"}.

Sera were produced by inoculation of specific pathogen-free chickens with whole influenza viruses, in accordance with OIE guidelines (World Organization for Animal Health). If necessary, sera were pre-adsorbed with chicken red blood cells (RBCs). Other pre-treatments (e.g., decomplementation at 56 °C for 30 min, treatment with receptor-destroying enzymes) were not performed.

3.2. Pseudotype Particles and Pseudotype Particle Neutralization Assays {#sec3dot2-pathogens-06-00045}
-----------------------------------------------------------------------

Lentiviral pseudotyped particles were produced as described previously \[[@B8-pathogens-06-00045],[@B19-pathogens-06-00045]\]. Briefly, the HIV gag-pol plasmid p8.91, the firefly luciferase-expressing plasmid pCSFLW, the HA-expressing plasmid ([Table 3](#pathogens-06-00045-t003){ref-type="table"}), and the pCAGGS-TMPRSS2 or HAT were co-transfected into human embryonic kidney HEK293T/17 cells using Polyethylenimine (PEI). After 24 h incubation, 1 U of recombinant neuraminidase from *Clostridium perfringens* (Sigma) was added to facilitate pseudotype exit from the producer cells. Supernatant was harvested forty-eight hours post-transfection, filtered through 0.45 μm filters, and stored at −80 °C.

The pp-NTs were performed as described elsewhere \[[@B19-pathogens-06-00045]\], using 5 µL of each serum sample (starting dilution 1:40) and using a pp input of 1 × 10^6^ RLU/well. IC~50~ neutralization titres were calculated using GraphPad Prism^®^ expressed as dilution factor; then for further statistical analysis, they were categorised into 17 groups according to the dilution tested and as reported in [Table 4](#pathogens-06-00045-t004){ref-type="table"}.

A cross-reactivity map (pp versus reference antisera) completed using the neutralization groups for further statistical analysis, was designed in a Microsoft^®^ Excel 2011 spread sheet and then saved as a comma-separated values (csv) file.

3.3. Bioinformatic Analysis {#sec3dot3-pathogens-06-00045}
---------------------------

Percentage identity between HA amino acid sequences of pp and reference sera antigens were calculated to check if cross-reactivity could be explained by overall sequence similarity. Amino acid sequences of the HA used in neutralization assays, and used to generate the reference antisera, were downloaded from the Influenza Virus Resource, the Influenza Research database, and the Global Initiative on Sharing Avian Influenza Data (GISAID) EpiFlu™ platform \[[@B20-pathogens-06-00045]\]. The accession numbers of the HAs used in pp-NT assays are reported in [Table 3](#pathogens-06-00045-t003){ref-type="table"}; HA accession numbers of the reference antisera are reported in [Table 1](#pathogens-06-00045-t001){ref-type="table"} and [Table 2](#pathogens-06-00045-t002){ref-type="table"}. For A/mallard/Italy/3817-34/2005 (H9N2), the HA sequence was not available at the time of analysis, and therefore the pp sequence was used as a reference. Additionally, some of the HA sequences in the databases were incomplete, which complicates the analysis. To minimize this, it was decided to evaluate the percentage identity only for the amino acids that constitute the extracellular part of the HA (amino acids from 24 to 547 using H3 numbering), which were available for all HAs used. All sequences were aligned using MUSCLE algorithm \[[@B21-pathogens-06-00045]\] and Jalview software \[[@B22-pathogens-06-00045]\]. Subsequently, the sequences were trimmed of their N-terminal signal sequence, the transmembrane region, and the cytoplasmic tail. Percentage identities between amino acid sequences were calculated by pair-wise alignments using Jalview before being reported in a Microsoft^®^ Excel 2011 spreadsheet and saved as a csv file. The phylogenetic trees shown alongside the cross-reactivity and the percentage identity tables were generated using Molecular Evolutionary Genetics Analysis (MEGA) software \[[@B23-pathogens-06-00045]\]: the aligned sequences were imported and trees derived using Unweighted Pair Group Method with Arithmetic mean (UPGMA), the simplest method of tree construction based on pairwise evolutionary distances. The trees generated were manually modified using MEGA and FigTree (<http://tree.bio.ed.ac.uk/software/figtree/>).

3.4. Statistical Analysis {#sec3dot4-pathogens-06-00045}
-------------------------

Cross-reactivity tables for the IC~50~ neutralization titres, expressed as group, and for percentage amino acid identity, were completed using Microsoft^®^ Excel 2011. R statistical software was then used to analyse the data and design a "heat-map" which colour codes the neutralization titres and the percentage identity. These codes are based on the use of the software package "RColorBrewer"(which permits a personalised colour palette to be built), and "gplots", a package that contains functions for the graphical interface. The "heatmap.2" function was eventually used to assign a colour to each IC~50~ group or percentage identity value. Kendall τ (tau) statistics ("Kendall" package) was also run using R software to check if association/correlation between measured IC~50~ titres and percentage identity was present.

4. Conclusions {#sec4-pathogens-06-00045}
==============

To conclude, the results presented here show that the high sensitivity and the propensity of the pp-NT assay to detect cross-reactive responses does not permit the use of current chicken reference standard antisera as reference materials to validate the assay. Until more appropriate standards (e.g., ferret sera or monoclonal antibody mixtures) are developed to further progress optimisation and validation of the pp-NT assay, the routinely used reference standards should be used as positive neutralization controls only in experimental research settings.
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![Cross-reactivity map of pseudotype particles (pp) and reference sera based on IC~50~. The IC~50~ values used for the cross-reactivity heat map were the result of arithmetic means between one or more different experiments performed when the same batch of sera and the same batch of pp were available, in order to minimize potential additional variability factors. Note: H7N7 (1) is A/turkey/England/647/1977 (H7N7) and H7N7 (2) is A/England/268/1996 (H7N7).](pathogens-06-00045-g001){#pathogens-06-00045-f001}

![Cross-reactivity map of pp and reference sera based on percentage of amino acid identity. Percentage identities between haemagglutinin (HA) amino acid sequences trimmed of their N-terminal signal, the transmembrane region, and the cytoplasmic tail were calculated by pair-wise alignments using Jalview and coloured using the heatmap function in R. In the figure, H7N7 (1) is A/turkey/England/647/1977 (H7N7) and H7N7 (2) is A/England/268/1996 (H7N7).](pathogens-06-00045-g002){#pathogens-06-00045-f002}

pathogens-06-00045-t001_Table 1

###### 

IZSVe avian influenza reference antisera for haemagglutination inhibition assay, agar gel immunodiffusion test, and agar gel precipitation test.

  Antigen Strain Name                     Subtype   HA Accession Number   HI Titre
  --------------------------------------- --------- --------------------- ----------
  A/duck/Italy/1447/2005                  H1N1      HF563054.1            1:512
  A/duck/Germany/1215/1973                H2N3      CY014710.1            1:512
  A/psittacine/Italy/2873/2000            H3N8      GQ247846.1 \*         1:256
  A/cockatoo/England/1972                 H4N8      GQ247847.1 \*         1:128
  A/turkey/Canada/1965                    H6N2      GQ247851.1 \*         1:256
  A/turkey/Ontario/6118/1968              H8N4      CY014659.1            1:512
  A/mallard/Italy/3817-34/2005            H9N2      Not Applicable        1:256
  A/ostrich/South Africa/2001             H10N1     GQ247860.1 \*         1:512
  A/duck/Memphis/546/1974                 H11N9     AB292779.1            1:1024
  A/duck/Alberta/60/1976                  H12N5     CY130078.1            1:128
  A/gull/Maryland/704/1977                H13N6     D90308.1              1:1024
  A/mallard/Gurjev/263/1982               H14N5     M35997                1:512
  A/shearwater/Australia/2576/1979 \*\*   H15N9     CY130102.1            1:2048
  A/gull/Denmark/68110/2002               H16N3     GQ247872.1 \*         1:256

\* Partial sequence; \*\* Also known as A/shearwater/West Australia/2576/1979.

pathogens-06-00045-t002_Table 2

###### 

Animal and Plant Health Agency (APHA) avian influenza reference antisera.

  Antigen Strain Name                   Subtype   HA Accession Number   HI Titre
  ------------------------------------- --------- --------------------- ---------------
  A/chicken/Scotland/1959               H5N1      CY015081.1            Not available
  A/African starling/England/983/1979   H7N1      AF202232.1            Not available
  A/chicken/Wales/1306/2007             H7N2      EF675618.1            Not available
  A/chicken/England/4054/2006           H7N3      EF467826.1            Not available
  A/England/268/1996                    H7N7      AF028020.1            Not available
  A/turkey/England/647/1977             H7N7      AF202247.1            Not available

pathogens-06-00045-t003_Table 3

###### 

Haemagglutinin-encoding plasmids used for pseudotype production.

  Plasmid Backbone   HA                                          HA Accession Number
  ------------------ ------------------------------------------- ---------------------
  pI.18              A/duck/Italy/1447/2005 H1                   HF563054.1
  pI.18              A/Korea/426/1968 H2                         CY125846.1
  phCMV1             A/duck/Germany/1215/1973 H2                 CY014710.1
  pI.18              A/Udorn/307/1972 H3                         DQ508929.1
  phCMV1             A/duck/Czechoslovakia/1956 H4               D90302.1
  pI.18              A/Vietnam/1194/2004 H5                      ABP51976.1
  pI.18              A/chicken/Italy/1082/1999 H7                ABR37396.1
  phCMV1             A/turkey/Ontario/6118/1968 H8               CY014659.1
  pI.18              A/Hong Kong/1073/1999 H9                    AJ404626.1
  phCMV1             A/chicken/Germany/N49 H10                   CY014671.1
  phCMV1             A/duck/Memphis/546/1974 H11                 AB292779.1
  phCMV1             A/duck/Alberta/60/1976 H12                  CY130078.1
  phCMV1             A/gull/Maryland/704/1977 H13                D90308.1
  phCMV1             A/mallard/Astrakhan/263/1982 H14            AB289335.1
  phCMV1             A/shearwater/West Australia/2576/1979 H15   CY130102.1
  phCMV1             A/black-headed gull/Sweden/2/1999 H16       AY684888.1

pathogens-06-00045-t004_Table 4

###### 

Categories of IC~50~ values used for statistics.

  Group   IC~50~ Values   Dilution Factor
  ------- --------------- -----------------
  0       \<35            \<40
  1       35--45          40
  2       45--75          40--80
  3       75--85          80
  4       85--150         80--160
  5       150--170        160
  6       170--310        160--320
  7       310--330        320
  8       330--630        320--640
  9       630--670        640
  10      670--1270       640--1280
  11      1270--1290      1280
  12      1290--2550      1280--2560
  13      2550--2570      2560
  14      2570--5100      2560--5120
  15      5100--5140      5120
  16      \>5140          \>5120
